A: According to ro.co and standard medical practice, yes, switching medications is possible if: Experiencing intolerable side effects despite management strategies Inadequate weight loss response after appropriate trial period Other medical reasons make alternative more appropriate Considerations When Switching : Insurance coverage may differ between medications (new prior authorization required) Must restart dose escalation schedule with new medication Some side effects common across all GLP-1s (switching may not resolve all issues) Switching incurs additional costs and time delay Provider discretion required Discuss thoroughly with provider before deciding to switch
Each vial contains high-purity GLP-1 supplied as a sterile lyophilized powder designed to preserve peptide stability before reconstitution
Being ill or having ongoing pain can also lead to feeling more tired than usual
Yes, possible side effects include mild nausea or changes in appetite
The expression and distribution of FFARs such as GPR40, GPR119, and GPR120 in L and cells and glucose, along with their dual effects on insulin and GLP-1 secretion, have made them attractive therapeutic targets, leading to the development of agonists for these receptors for the treatment of T2DM [150,151,152,153,154]
During trials, subjects started the dosage at 2mg once per week, injecting into the stomach or thigh area and slowly increasing the dosage per week or even split dosing the product twice a week
